Videos & Presentations

Our Purpose:
To be a driving force in the early detection of lung cancer.

September 9, 2021

Half Year Results to 30 June, 2021

Paul Pagano and David Anderson talk with Justin Waite of VOX Markets. Paul Pagano and David Anderson's presentation to the investor community on the results to the period.
• View Media
July 9, 2021

Introduction to LungLife AI, Inc post Admission

Paul Pagano talks with Paul Hill of VOX Markets following the Company's IPO on 8 July, 2021.
• View Media

Media inquiries

© 2020 LungLIfe AI, Inc.
All rights reserved. LiquidBiopsy is a trademark of LungLife AI, Inc.